当前位置:首页 - 行情中心 - 康泰医学(300869) - 财务分析 - 利润表

康泰医学

(300869)

  

流通市值:23.53亿  总市值:35.84亿
流通股本:2.64亿   总股本:4.02亿

利润表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、营业总收入353,739,898.59225,877,603.09100,279,216.75468,004,884.41
  营业收入353,739,898.59225,877,603.09100,279,216.75468,004,884.41
二、营业总成本394,728,383.53255,161,799.97114,012,396.72496,009,962.87
  营业成本190,081,293.89116,447,191.7648,347,008.24243,142,442.81
  税金及附加4,229,743.233,216,561.212,185,955.667,709,699.75
  销售费用68,327,369.8445,141,581.6919,589,070.3109,966,081.06
  管理费用31,681,500.4720,728,272.9810,638,696.2839,475,990.05
  研发费用66,098,060.144,757,297.8521,701,198.8291,658,946.04
  财务费用34,310,41624,870,894.4811,550,467.424,056,803.16
  其中:利息费用---37,428,972.59
  其中:利息收入---49,801,528.24
三、其他经营收益
  加:公允价值变动收益2,287,664.22,327,222.032,334,068.881,773,267.48
  加:投资收益8,858,492.328,367,926.282,016,982.916,729,120.38
  资产处置收益0--171.89
  资产减值损失(新)-31,524,206.1-33,668,249.14--28,148,237.76
  信用减值损失(新)153,621.79165,133.6239,253.891,354,502.84
  其他收益1,064,350.02869,171.47310,190.799,963,375.98
四、营业利润-60,148,562.71-51,222,992.64-8,832,683.51-26,332,877.65
  加:营业外收入1,385,479.02773,046.52273,863.321,086,164.45
  减:营业外支出366,495.89164,639.88152,586.651,639,226.21
五、利润总额-59,129,579.58-50,614,586-8,711,406.84-26,885,939.41
  减:所得税费用-1,847,127.08-1,346,602.72-469,636.88-2,462,078.36
六、净利润-57,282,452.5-49,267,983.28-8,241,769.96-24,423,861.05
(一)按经营持续性分类
  持续经营净利润-57,282,452.5-49,267,983.28-8,241,769.96-24,423,861.05
(二)按所有权归属分类
  归属于母公司股东的净利润-57,282,452.5-49,267,983.28-8,241,769.96-24,423,861.05
  扣除非经常损益后的净利润-68,515,131.56-59,602,413.58-12,231,865.25-47,342,312.74
七、每股收益
  (一)基本每股收益-0.14-0.12-0.02-0.06
  (二)稀释每股收益-0.14-0.12-0.02-0.06
八、其他综合收益-1,931,421.5-1,472,891.17-806,737.63-625,845.49
  归属于母公司股东的其他综合收益-1,931,421.5-1,472,891.17-806,737.63-625,845.49
九、综合收益总额-59,213,874-50,740,874.45-9,048,507.59-25,049,706.54
  归属于母公司股东的综合收益总额-59,213,874-50,740,874.45-9,048,507.59-25,049,706.54
公告日期2026-10-302026-08-282026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑